Are you Dr. Tuveson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
15 Penn Tower
Philadelphia, PA 19104Phone+1 215-662-3914
Summary
- Dr. David Tuveson, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and New York.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000
Johns Hopkins University School of MedicineClass of 1994
Certifications & Licensure
NY State Medical License 2013 - 2026
PA State Medical License 2003 - 2014
Clinical Trials
- Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) Start of enrollment: 2011 Feb 01
- Famotidine Outpatient COVID-19 Treatment Study Start of enrollment: 2020 May 12
Publications & Presentations
PubMed
- 2 citationsMARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer.Olaf Klingbeil, Damianos Skopelitis, Claudia Tonelli, Toyoki Yoshimoto, Aktan Alpsoy
Cancer Discovery. 2024-12-02 - Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.Camino Bermejo-Rodriguez, Joaquín Araos Henríquez, Giuseppina Caligiuri, Sara Pinto Teles, Youngkyu Park
Cancer Research. 2024-09-16 - 5 citationsCytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells.Tajinder Ubhi, Olga Zaslaver, Andrew T Quaile, Dennis Plenker, Pinjiang Cao
Nature Cancer. 2024-06-01
Authored Content
- Successful Creation of Pancreatic Cancer Organoids by Means of EUS-Guided Fine-Needle Biopsy for Personalized Cancer TreatmentJanuary 2018
Press Mentions
How Pancreatic Cancer Can Be Accelerated by a Splicing-Regulator ProteinApril 27th, 2023- Exploration of a Large Virtual Chemical Space: Identification of Potent Inhibitors of Lactate Dehydrogenase-a Against Pancreatic CancerJanuary 16th, 2023
- LI Scientists Seek to Find Out Why Colon Cancer Is Higher Among BlacksNovember 11th, 2022
- Join now to see all
Grant Support
- Mutant Mouse Models Of Exocrine Pancreatic CancerNational Cancer Institute2007–2008
- Mutant Mouse Models Of Exocrine Pancreatic CancerNational Cancer Institute2004–2006
